Matthew X. Lowe, Ph.D.

About

Dr. Matthew X. Lowe is a trained research scientist, educator, and experienced advisor who has spent over 15 years researching human brain function and behavior across a range of topics in cognition, perception, mental health, psychedelics, and cannabis use. Dr. Lowe has been named one of the top 25 emerging leaders in psychedelic research and modern theory and an innovator shaping the future of psychedelic science. After receiving his doctorate in psychology and cognitive neuroscience at the University of Toronto, Matthew completed his postdoctoral work at MIT and Harvard. Following his postdoctoral work, he was Research Director at the Stanford Cognitive & Systems Neuroscience Laboratory. In his current work, he is a passionate advocate for evidence-based research and education on health outcomes related to the use of plant-based and other natural medicines, and has published research on psilocybin, ayahuasca, and cannabis.

Dr. Lowe is currently the Director of Research for Realm of Caring (www.realmofcaring.org), a 501(c)(3) non-profit cannabis research organization which seeks to facilitate and encourage the mainstream acceptance of transformative, plant-powered therapies to benefit individuals and families and serve healthcare providers as well as the hemp and cannabis industries. He is also the Executive Director & Chief Scientific Officer for Realm of Caring's fiscally sponsored partner, Unlimited Sciences (www.unlimitedsciences.org), a psychedelics research non-profit using data-driven methods to inform public perception, education, policy, and practices for psychedelics use. Additionally, he is Scientific Advisor and Lead Educator for the Oregon Psilocybin Center (www.oregonpsilocybincenter.com) where he lectures as a licensed Career School Teacher.

He is currently a Principal Investigator for the Cannabis & Health Research Inititative (www.cannabisandhealth.org), a largescale NIH/NIDA funded research initiative on cannabis health outcomes, as well as several IRB-approved studies on psychedelics and cannabis. His work has been featured in Forbes, Vice, Yahoo!, Web MD, Business Insider, The Denver Post, High Times, DoubleBlind, Benzinga, and dozens of other media outlets.